tiprankstipranks
Trending News
More News >
Neuren Pharmaceuticals Limited (AU:NEU)
ASX:NEU

Neuren Pharmaceuticals Limited (NEU) Revenue

Compare
277 Followers

Neuren Pharmaceuticals Limited Revenue

Neuren Pharmaceuticals Limited had a revenue of 28.28M in the quarter ending Jun 30, 2025, with -85.31%. This bring the company's revenue in the last twelve months to 220.78M, Decreased 1.82%. In the fiscal year ending Dec 31, 2024, Neuren Pharmaceuticals Limited had annual revenue of 213.24M with -8.06% growth.
Revenue (ttm)
220.78M
Revenue Growth
12.35%
P/S Ratio
11.58
Revenue/Employee
AU$26,655,375
Employees
8
Market Cap
AU$2.47B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
213.24M-18.68M+91.94%
Dec 31, 2023
231.93M217.37M+1,593.66%
Dec 31, 2022
14.55M11.36M+455.21%
Dec 31, 2021
3.20M2.48M+445.89%
Dec 31, 2020
717.00K222.00K+144.85%
Dec 31, 2019
495.00K-13.49M+3.54%
Dec 31, 2018
13.99M13.36M+2,217.12%
Dec 31, 2017
631.00K-2.52M+20.03%
Dec 31, 2016
3.15M